Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

The immune space: a concept and template for rationalizing vaccine development.

Manrique A, Adams E, Barouch DH, Fast P, Graham BS, Kim JH, Kublin JG, McCluskey M, Pantaleo G, Robinson HL, Russell N, Snow W, Johnston MI.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1017-22. doi: 10.1089/AID.2014.0040. Epub 2014 Jun 26.

2.

HIV vaccine development--improving on natural immunity.

Johnston MI, Fauci AS.

N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621. No abstract available.

3.

An HIV vaccine--challenges and prospects.

Johnston MI, Fauci AS.

N Engl J Med. 2008 Aug 28;359(9):888-90. doi: 10.1056/NEJMp0806162. No abstract available.

4.

HIV vaccine research: the way forward.

Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC.

Science. 2008 Jul 25;321(5888):530-2. doi: 10.1126/science.1161000.

PMID:
18653883
5.

An HIV vaccine--evolving concepts.

Johnston MI, Fauci AS.

N Engl J Med. 2007 May 17;356(20):2073-81. Review. No abstract available.

PMID:
17507706
6.

A new era in HIV vaccine development.

Lau CY, Velasco PP, Johnston MI.

Expert Rev Anti Infect Ther. 2007 Apr;5(2):205-15. Review.

PMID:
17402836
7.

Current advances in HIV vaccines.

D'Souza MP, Allen M, Sheets R, Johnston MI.

Curr HIV/AIDS Rep. 2004 Apr;1(1):18-24. Review.

PMID:
16091219
8.

A case-control study of family composition in anorexia nervosa.

Eagles JM, Johnston MI, Millar HR.

Int J Eat Disord. 2005 Jul;38(1):49-54.

PMID:
15971238
9.

Policy rebuttal. HIV vaccine trial justified.

McNeil JG, Johnston MI, Birx DL, Tramont EC.

Science. 2004 Feb 13;303(5660):961. No abstract available.

PMID:
14963313
10.

Progress in the development of an HIV vaccine.

Tramont EC, Johnston MI.

Expert Opin Emerg Drugs. 2003 May;8(1):37-45. Review.

PMID:
14610910
11.

Medicine. The need for a global HIV vaccine enterprise.

Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnston MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao Y, Tramont E, Varmus H, Wasserheit JN.

Science. 2003 Jun 27;300(5628):2036-9.

PMID:
12829768
12.

HIV vaccine development.

Johnston MI.

Dev Biol (Basel). 2002;110:57-63.

PMID:
12477307
13.

HIV Vaccines: Biological and Clinical Considerations.

D'Souza MP, Allen MA, Johnston MI.

Curr Infect Dis Rep. 2002 Aug;4(4):359-368.

PMID:
12126613
14.

Progress in HIV vaccine development.

Johnston MI, Flores J.

Curr Opin Pharmacol. 2001 Oct;1(5):504-10. Review.

PMID:
11764777
15.

Optimism is growing as researchers move toward an AIDS vaccine.

Johnston MI.

AIDS Alert. 2001 Nov;16(11):137-41.

PMID:
11692664
16.

Season of birth in females with anorexia nervosa in Northeast Scotland.

Eagles JM, Andrew JE, Johnston MI, Easton EA, Millar HR.

Int J Eat Disord. 2001 Sep;30(2):167-75.

PMID:
11449450
17.

Immunization. Update: search for an AIDS vaccine.

Bende S, Johnston MI.

AIDS Read. 2000 Sep;10(9):526-32, 534-8. Review.

PMID:
11019448
18.

The role of nonhuman primate models in AIDS vaccine development.

Johnston MI.

Mol Med Today. 2000 Jul;6(7):267-70. Review.

PMID:
10859562
19.

Changes in the presenting features of females with anorexia nervosa in northeast Scotland, 1965-1991.

Eagles JM, Easton EA, Nicoll KS, Johnston MI, Millar HR.

Int J Eat Disord. 1999 Nov;26(3):289-94.

PMID:
10441244
20.

Should assays drive science or vice versa?

Johnston MI, Goudsmit J.

Lancet. 1997 Oct 11;350(9084):1108. No abstract available.

PMID:
10213588
21.

HIV vaccines: problems and prospects.

Johnston MI.

Hosp Pract (1995). 1997 May 15;32(5):125-8, 131-40. Review.

PMID:
9153142
22.

HIV/AIDS Vaccine Development: Challenges, Progress and Future Directions.

Johnston MI.

Rev Med Virol. 1996 Sep;6(3):123-140. No abstract available.

PMID:
10398453
23.

Progress in AIDS vaccine development.

Johnston MI.

Int Arch Allergy Immunol. 1995 Dec;108(4):313-7. Review.

PMID:
7580300
24.

Increasing incidence of anorexia nervosa in the female population of northeast Scotland.

Eagles JM, Johnston MI, Hunter D, Lobban M, Millar HR.

Am J Psychiatry. 1995 Sep;152(9):1266-71.

PMID:
7653679
25.

Publish and Be Sued? Potential Liability for Infringement Arising through Academic Research.

Pabst PL, Johnston MI.

Tissue Eng. 1995 Winter;1(4):379. doi: 10.1089/ten.1995.1.379. No abstract available.

PMID:
19877901
26.

Recent advances in AIDS vaccine research and development.

Johnston MI, Noe JS, Killen JY.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S317-23. Review.

PMID:
7865330
27.

Present status and future prospects for HIV therapies.

Johnston MI, Hoth DF.

Science. 1993 May 28;260(5112):1286-93. Review.

PMID:
7684163
28.

Interaction of C225SR1 mutant subunit of ribonucleotide reductase with R2 and nucleoside diphosphates: tales of a suicidal enzyme.

Mao SS, Holler TP, Bollinger JM Jr, Yu GX, Johnston MI, Stubbe J.

Biochemistry. 1992 Oct 13;31(40):9744-51.

PMID:
1390750
29.

A model for the role of multiple cysteine residues involved in ribonucleotide reduction: amazing and still confusing.

Mao SS, Holler TP, Yu GX, Bollinger JM Jr, Booker S, Johnston MI, Stubbe J.

Biochemistry. 1992 Oct 13;31(40):9733-43.

PMID:
1382592
30.

Computer-assisted structure-activity correlations of halodideoxynucleoside analogs as potential anti-HIV drugs.

Nasr M, Cradock J, Johnston MI.

AIDS Res Hum Retroviruses. 1992 Feb;8(2):135-44.

PMID:
1540402
31.

Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product.

Kaminchik J, Bashan N, Pinchasi D, Amit B, Sarver N, Johnston MI, Fischer M, Yavin Z, Gorecki M, Panet A.

J Virol. 1990 Jul;64(7):3447-54.

32.

Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.

Morrey JD, Warren RP, Okleberry KM, Burger RA, Johnston MI, Sidwell RW.

J Acquir Immune Defic Syndr. 1990;3(5):500-10.

PMID:
2157836
33.

Induction of the 2-5A system by interferon and transmissible gastroenteritis virus.

Bosworth BT, MacLachlan NJ, Johnston MI.

J Interferon Res. 1989 Dec;9(6):731-9.

PMID:
2481702
34.

HIV proteinase as a target for drug action.

Johnston MI, Allaudeen HS, Sarver N.

Trends Pharmacol Sci. 1989 Aug;10(8):305-7. Review. No abstract available.

PMID:
2686126
35.

Mechanism-based inhibition of a mutant Escherichia coli ribonucleotide reductase (cysteine-225----serine) by its substrate CDP.

Mao SS, Johnston MI, Bollinger JM, Stubbe J.

Proc Natl Acad Sci U S A. 1989 Mar;86(5):1485-9.

36.

Raman spectroscopy of interferon-induced 2',5'-linked oligoadenylates.

White JC, Williams RW, Johnston MI.

Biochemistry. 1987 Dec 1;26(24):7737-44.

PMID:
2447947
37.

Antibody-nucleic acid interactions. Antibodies to psoralen-modified RNA as probes of RNA structure.

Hurt DJ, Winestock KD, O'Connor ML, Johnston MI.

Nucleic Acids Res. 1987 Nov 11;15(21):9057-73.

38.

Purification and characterization of a 2'-phosphodiesterase from bovine spleen.

Johnston MI, Hearl WG.

J Biol Chem. 1987 Jun 15;262(17):8377-82.

39.
40.
41.

Antibody-nucleic acid interactions. Monoclonal antibodies define different antigenic domains in 2',5'-oligoadenylates.

Johnston MI, Imai J, Lesiak K, Jacobsen H, Sawai H, Torrence PF.

Biochemistry. 1985 Aug 13;24(17):4710-8.

PMID:
2415159
42.

Immunochemistry, physical chemistry and biology of 2',5'-oligoadenylates.

Johnston MI, Hearl WG, White JC, Imai J, Torrence PF, Williams RW.

Prog Clin Biol Res. 1985;202:37-45.

PMID:
2421316
43.

Levels of 2',5'-oligoadenylates in the tissues of pathogen-free mice.

Hearl WG, Johnston MI.

Prog Clin Biol Res. 1985;202:19-24.

PMID:
2421302
44.

A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.

Johnston MI, Preble OT, Imai J, Jacobsen H, Torrence PF.

J Immunol Methods. 1983 Dec 16;65(1-2):123-35.

PMID:
6361140
46.

Assay of 2',5'-oligoadenylate phosphodiesterase activity in mouse L-cell extracts.

Torrence PF, Imai J, Johnston MI.

Anal Biochem. 1983 Feb 15;129(1):103-10.

PMID:
6305230
47.

Cordycepin analogues of 2-5A and its derivatives. Chemical synthesis and biological activity.

Sawai H, Imai J, Lesiak K, Johnston MI, Torrence PF.

J Biol Chem. 1983 Feb 10;258(3):1671-7.

48.

Chemical modification potentiates the biological activities of 2-5A and its congeners.

Imai J, Johnston MI, Torrence PF.

J Biol Chem. 1982 Nov 10;257(21):12739-45.

49.

Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.

Imai J, Lesiak K, Johnston MI, Torrence PF.

Nucleic Acids Symp Ser. 1982;(11):97-100.

PMID:
7183979

Supplemental Content

Loading ...
Support Center